The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project.

Headline
The Centers for Medicare & Medicaid Services May 5 announced a new electronic prior authorization initiative as part of its Health Technology Ecosystem.…
Headline
For families living in poverty, accessing health care can feel out of reach — buried beneath challenges like transportation, childcare and job insecurity…
Headline
The Food and Drug Administration April 28 announced its plan to advance the implementation of real-time clinical trials, which invite participants to supply…
Headline
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.In the statement, the AHA…
Blog
Public
The American Hospital Association Leadership Summit will take place July 12-14 at the Colorado Convention Center in Denver. Renowned speakers from across…
Blog
Public
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…